Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Litaphar is a Mexican pharmaceutical company specializing in the production and commercialization of generic and over-the-counter (OTC) medicines. Founded in 1994, the company offers a diverse portfolio of products targeting therapeutic areas such as pain management, infectious diseases, and gastroenterology. Litaphar operates manufacturing facilities in Mexico, focusing on providing accessible and high-quality healthcare solutions to the domestic market. Their product line includes well-known generic formulations like naproxen, paracetamol, and various antibiotics. The company maintains strict adherence to Good Manufacturing Practices (GMP) to ensure the safety and efficacy of its medications. Litaphar serves as a key supplier to both private pharmacies and public health institutions within the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios LITAPHAR.